With parameters of transformation other than immortality (3). Another logical possibility is that the ability to induce DNA synthesis in senescent HDC might be associated with viral transformation. Cells transformed by viruses may have gained a factor that overrides the inhibitory effect of senescent HDC, whereas carcinogen-transformed cells may have lost a normal factor necessary for the expression ofsenescence while retaining their sensitivity to the putative inhibitor when it is supplied to them in heterodikaryons. We have tested these hypotheses by fusing senescent HDC to a series of transformed human cells that have various transformed properties and were transformed in different ways.
Cell fusion between nonreplicative senescent human diploid cells (HDC) and replicative cells ofvarious types has been used to probe the mechanism for control of cell proliferation in normal and transformed cells. When senescent HDC are fused to young HDC, they are not induced to synthesize DNA in the resulting heterodikaryons (1) . Rather, the young HDC nuclei in these heterodikaryons are inhibited from entering S phase (2) . Ongoing DNA synthesis in the young HDC nuclei does not appear to be inhibited. These results suggest that senescent HDC may contain an inhibitor of entry into S phase.
When senescent HDC are fused to immortal transformed cells, two different results are obtained. T98G human glioblastoma cells and RK13 rabbit kidney cells are inhibited from entering S phase in the same manner as young HDC are inhibited (3) whereas HeLa and SV80 [simian virus 40 (SV40)-transformed human skin] cells induce DNA synthesis in senescent HDC nuclei in heterodikaryons (4) . These results indicate that senescent HDC can be reactivated to synthesize DNA but that not all immortal cell lines have this capability. HeLa and SV80 cells are "more fully transformed" than are T98G and RK13 cells, both of which still express the normal quiescent phenotype of G1 arrest with long-term viability under suboptimal growth conditions. This difference suggested that the ability to induce DNA synthesis in senescent HDC might be correlated With parameters of transformation other than immortality (3) . Another logical possibility is that the ability to induce DNA synthesis in senescent HDC might be associated with viral transformation. Cells transformed by viruses may have gained a factor that overrides the inhibitory effect of senescent HDC, whereas carcinogen-transformed cells may have lost a normal factor necessary for the expression ofsenescence while retaining their sensitivity to the putative inhibitor when it is supplied to them in heterodikaryons. We have tested these hypotheses by fusing senescent HDC to a series of transformed human cells that have various transformed properties and were transformed in different ways.
MATERIALS AND METHODS
Our procedures for cell culture, cell fusion, autoradiography, and identification of heterodikaryons have been described (2, 3, 5) .
In these experiments, the senescent HDC were either IMR-90 or WI-38 fetal lung fibroblasts at 48-53 population doublings. Forty-eight hours before fusion, senescent HDC were labeled with both [3H]thymidine (0.5 ,Ci/ml; 1 Ci = 3.7 X 10'°b ecquerels) and 2-,um-diameter latex beads (Dow 
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The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. dikaryons were identified as having at least 10 beads ofjust one size, whereas heterodikaryons had at least 10 beads of both sizes. In all heterodikaryons, it was possible to distinguish the senescent HDC nuclei from the transformed cell nuclei based on morphological differences (2) . RESULTS Senescent HDC were fused to SUSM-1 chemically transformed human cells and to T98 glioblastoma cells to determine whether the ability to induce DNA synthesis in senescent HDC is correlated with loss ofthe normal quiescence phenomenon. Unlike the previously tested T98G and RK13 cells (3), SUSM-1 and T98 do not completely cease DNA synthesis under stationary phase conditions. The rate of proliferation in these cultures decreases to a plateau of 20-25% [3H]thymidine-labeled nuclei per 24-hr labeling period for both SUSM-1 ( Fig. 1 ) and T98 (11) . SUSM-1 and T98 cells also differ from T98G in their response to a wound made in a confluent monolayer ( 24 hr and then processed for autoradiography. (11) . Wound serum requirement, topoinhibition, and compensation for topoinhibition are defined and calculated according to Dulbecco (12) .
when senescent HDC were fused to T98 cells (data not shown). Thus, SUSM-1 and T98 cells are sensitive to inhibition by senescent HDC in the same manner as previously shown for young HDC, T98G, and RK13 cells. These results imply that the ability to induce DNA synthesis in senescent HDC is not correlated with loss of the normal quiescence phenomenon.
Senescent HDC were fused to tumorigenic HUT-li chemically transformed human cells (8) RNA virus-transformed cell line that we have tested lack the ability to induce DNA synthesis in senescent HDC. The phenomenon ofcellular senescence can be explained in the following way. We propose that a continually decreasing ability to utilize mitogenic growth factors is the fundamental change that takes place in HDC as theyprogress toward the end of their proliferative lifespan. Consequently, these cells reach a point at which they are physiologically serum-deprived even though they are incubated in high-serum-containing medium. According to our model, this serum deprivation triggers the production of an inhibitor of entry into S phase that puts the cells in a viable quiescent state. This hypothesis is consistent with the following properties ofsenescent HDC: (i) they remain viable as nonreplicative cells for many months; (ii) they have G1 phase DNA contents (18) ; (iii) they behave like serum-deprived young HDC in heterodikaryons (5, 19) ; and (iv) as they age in vitro, they require continually increasing amounts of serum to maintain a constant rate of proliferation (20) .
DISCUSSION
The inhibitor hypothesis described above is consistent with previous observations on similarities between normal cells, carcinogen-transformed cells, and RNA virus-transformed cells and differences between these cells and DNA virus-transformed cells. When normal cells are subjected to poor growth conditions such as serum deprivation, deprivation of growth factors in a defined medium, high cell density, Ca"+ deprivation, protein synthesis inhibition with cycloheximide, and treatment with picolinic acid, they arrest in the G1 phase of the cell cycle. When carcinogen-transformed cells or RNA virus-transformed cells are subjected to the same treatments, they also accumulate in GC (13, 14, (21) (22) (23) (24) (25) (33) . These results are consistent with the inhibitor hypothesis suggested by our heterokaryon experiments. SV40-transformed cells may be stimulated to produce the inhibitor under restrictive growth conditions, but they themselves cannot respond to it because they make a transforming factor that overrides its activity. Evidence that large tumor antigen is sufficient for the maintenance of transformation in type N SV40-transformed cells (35) suggests that it may be the transforming factor that overrides the putative inhibitor.
